Journal details
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
CIG MEDIA GROUP, LP · ISSN 2152-2650 · eISSN 2152-2669
SCIEScopusMEDLINEPubMedPMC
Overview
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. ISSN 2152-2650 · eISSN 2152-2669. published by CIG MEDIA GROUP, LP. United States. Oncology · Hematology. impact factor 4.1 (2025). JCR Q1. CAS Zone 4. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 107 articles · 2025: 3,477 articles · 2024: 2,200 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CLINICAL LYMPHOMA MYELOMA & LEUKEMIA?
The impact factor recorded for CLINICAL LYMPHOMA MYELOMA & LEUKEMIA is 4.1 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CLINICAL LYMPHOMA MYELOMA & LEUKEMIA?
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA is listed in CAS Zone 4.
Which databases index CLINICAL LYMPHOMA MYELOMA & LEUKEMIA?
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.